Primary study · included by 1 review

Safety and efficacy of a Nav1.7 selective sodium channel blocker in patients with trigeminal neuralgia: a double-blind, placebo-controlled, randomised withdrawal phase 2a trial.

Zakrzewska 2017 · Zakrzewska Joanna M, Palmer Joanne, Morisset Valerie, et al. · The Lancet. Neurology · 2017

Included by

A meta-analysis of pain intensity changes after placebo interventions in facial pain.

Non-Cochrane · other · 2026 · cited as Zakrzewska 2017 · Results para 1 included-study citation list (ref 129); 116 refs cited for 115 stated studies; Supplemental Tables 1 and 2 not available

The review does not say which of its outcomes this study informs.

1 including review in total.